Understanding treatment education for severe asthma patients
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study asks adults with severe asthma who have been on biologic treatments for at least 6 months to share their educational needs in interviews. The goal is to improve support for people using these therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have severe asthma and have been on one of these treatments for at least 6 months: omalizumab, benralizumab, mepolizumab, dupilumab, or tezepelumab.
- You are able to speak French and travel to an in-person interview.
- You are not under legal guardianship or conservatorship.
- Your asthma is not linked to another systemic disease like GEPA or ABPA.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study surveys patients who have been on a biologic treatment for severe asthma for at least 6 months but not longer than 18 months. It aims to understand their experience, including those who did not respond well to the treatment.
This study explores what it's like to live with severe asthma as a young adult. It uses interviews or focus groups to understand your experiences, to help improve care for others like you.
This study tests if a personalized exercise program can help adults with severe asthma who are starting a new biologic treatment. It aims to improve symptoms and quality of life.
This study looks at how well different biologic treatments work for people with severe or mild-to-moderate asthma, and compares them to healthy volunteers. It aims to find which treatments work best for different asthma types.
This study set up a long-term asthma registry to better understand people with severe asthma and what treatments they use. If you fit the asthma severity requirements, you may be asked for consent and basic health information so the team can follow your asthma over time.
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
Hear when a new Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.